CommercialJune 22, 2018
Medical policy and clinical guidelines updates are available on anthem.com
The following new and revised medical policies and clinical guidelines were endorsed at the March 22, 2018 Medical Policy & Technology Assessment Committee (MPTAC) meeting. These, and all Anthem medical policies, are available at anthem.com/provider > Select a state > Find Resources for [state] > Medical Policies and Clinical UM Guidelines.
If you do not have access to the Internet, you may request a hard copy of any updated policy by contacting the Provider Call Center.
Please note that the Federal Employee Program® Medical Policy Manual may be accessed at www.fepblue.org > Benefit Plans > Brochures and Forms > Medical Policies.
Revised medical policies effective March 29, 2018
(The following policies were revised to expand medical necessity indications or criteria.)
DRUG.00078 - Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors
GENE.00028 - Genetic Testing for Colorectal Cancer Susceptibility
SURG.00098 - Mechanical Embolectomy for Treatment of Acute Stroke
New medical policy effective March 29, 2018
(The policy below is new and determined to not have significant change.)
MED.00120 - Voretigene neparvovec (Luxturna™)
Revised medical policies effective April 25, 2018
(The following policies were revised to expand medical necessity indications or criteria.)
DME.00009 - Vacuum Assisted Wound Therapy in the Outpatient Setting
RAD.00029 - CT Colonography (Virtual Colonoscopy) for Colorectal Cancer
SURG.00121 - Transcatheter Heart Valve Procedures
Revised medical policies effective April 25, 2018
(The following policies were reviewed and may have word changes or clarifications, but had no significant changes to the policy position or criteria.)
ANC.00008 - Cosmetic and Reconstructive Services of the Head and Neck
DME.00032 - Automated External Defibrillators for Home Use
DRUG.00086 - Mecasermin (Increlex®)
DRUG.00108 - Edaravone (Radicava®)
GENE.00003 - Genetic Testing and Biochemical Markers for the Diagnosis of Alzheimer's Disease
GENE.00012 - Preconception or Prenatal Genetic Testing of a Parent or Prospective Parent
MED.00004 - Technologies for the Evaluation of Skin Lesions (including Dermatoscopy, Epiluminescence Microscopy, Videomicroscopy and Ultrasonography)
MED.00007 - Prolotherapy for Joint and Ligamentous Conditions
MED.00011 - Sensory Stimulation for Brain-Injured Individuals in Coma or Vegetative State
MED.00059 - Idiopathic Environmental Illness (IEI)
MED.00101 - Physiologic Recording of Tremor using Accelerometer(s) and Gyroscope(s)
RAD.00012 - Ultrasound for the Evaluation of Paranasal Sinuses
RAD.00038 - Use of 3-D, 4-D or 5-D Ultrasound in Maternity Care
RAD.00044 - Magnetic Resonance Neurography
RAD.00052 - Positional MRI
REHAB.00003 - Hippotherapy
SURG.00033 - Cardioverter Defibrillators
SURG.00043 - Electrothermal Shrinkage of Joint Capsules, Ligaments and Tendons
SURG.00045 - Extracorporeal Shock Wave Therapy for Orthopedic Conditions
SURG.00048 - Panniculectomy and Abdominoplasty
SURG.00053 - Unicondylar Interpositional Spacer
SURG.00056 - Transanal Radiofrequency Treatment of Fecal Incontinence
SURG.00061 - Presbyopia and Astigmatism-Correcting Intraocular Lenses
SURG.00062 - Ovarian and Internal Iliac Vein Embolization as a Treatment of Pelvic Congestion Syndrome
SURG.00066 - Percutaneous Neurolysis for Chronic Neck and Back Pain
SURG.00070 - Photocoagulation of Macular Drusen
SURG.00073 - Epiduroscopy
SURG.00079 - Nasal Valve Suspension
SURG.00096 - Surgical and Ablative Treatments for Chronic Headaches
SURG.00100 - Cryoablation for Plantar Fasciitis and Plantar Fibroma
SURG.00111 - Axial Lumbar Interbody Fusion
SURG.00145 - Mechanical Circulatory Assist Devices (Ventricular Assist Devices, Percutaneous Ventricular Assist Devices and Artificial Hearts)
SURG.00150 - Leadless Pacemaker
TRANS.00008 - Liver Transplantation
TRANS.00009 - Lung and Lobar Transplantation
TRANS.00011 - Pancreas Transplantation and Pancreas Kidney Transplantation
TRANS.00013 - Small Bowel, Small Bowel/Liver, and Multivisceral Transplantation
TRANS.00026 - Heart/Lung Transplantation
TRANS.00033 - Heart Transplantation
Archived medical policy effective June 22, 2018
(This policy is now an Anthem Clinical Guideline.)
DRUG.00092 - Buprenorphine Implant (Probuphine®)
Archived medical policies effective June 28, 2018
(These polices are now Anthem Clinical Guidelines.)
BEH-00004 - Activity Therapy for Autism Spectrum Disorders and Rett Syndrome
DRUG.00028 - Intravitreal Treatment for Retinal Vascular Conditions
DRUG.00032 - Intravitreal Corticosteroid Implants
DRUG.00072 - Alpha-1 Proteinase Inhibitor Therapy
DRUG.00101 - Sarilumab (Kevzara®)
LAB.00020 - Skin Nerve Fiber Density Testing
MED.00076 - Inhaled Nitric Oxide
RAD.00030 - Wireless Capsule Endoscopy for Gastrointestinal Imaging and the Patency Capsule
SURG.00081 - Total Ankle Replacement
SURG.00089 - Self-Expanding Absorptive Sinus Ostial Dilation
SURG.00110 - Transanal Endoscopic Microsurgical (TEM) Excision of Rectal Lesions
THER-RAD.00003 - Intravascular Brachytherapy (Coronary and Non-Coronary
Archived medical policy effective October 31, 2018
(This policy is now an MCG Behavioral Health Clinical Guideline.)
BEH.00001 - Opioid Antagonists under Heavy Sedation or General Anesthesia as a Technique of Opioid Detoxification
Revised medical policies effective September 1, 2018
(The following policies listed below might result in services that were previously covered now being considered either not medically necessary and/or investigational.)
DRUG.00003 - Chelation Therapy
OR.PR.00003 - Microprocessor Controlled Lower Limb Prostheses
SURG.00037 - Treatment of Varicose Veins (Lower Extremity)
SURG.00132 - Drug-Eluting Devices for Maintaining Sinus Ostial Patency
New medical policy effective September 1, 2018
(The policy below is new and may result in services previously covered now being considered either not medically necessary and/or investigational)
SURG.00151 - Balloon Dilation of Eustachian Tubes
Revised clinical guidelines effective April 25, 2018
(The following guidelines were revised and had no significant changes to the position or criteria.)
CG-BEH-02 - Adaptive Behavioral Treatment for Autism Spectrum Disorder
CG-BEH-03 - Psychiatric Disorder Treatment
CG-BEH-07 - Psychological Testing
CG-DRUG-27 - Clostridial Collagenase Histolyticum Injection
CG-DRUG-57 - Idursulfase (Elaprase®)
CG-MED-55 - Level of Care: Advanced Radiologic Imaging
CG-MED-68 - Therapeutic Apheresis
CG-SURG-09 - Temporomandibular Disorders
CG-SURG-27 - Sex Reassignment Surgery
CG-TRANS-02 - Kidney Transplantation
New and adopted clinical guidelines effective June 22, 2018
(The following guidelines were previously medical policies and have been adopted. No significant changes were made.)
CG-DRUG-89 - Implantable and Extended-Release Buprenorphine-Containing Products
CG-DRUG-92 - Alpha-1 Proteinase Inhibitor Therapy
New and adopted clinical guidelines effective June 28, 2018
(The following guidelines were previously medical policies and have been adopted. No significant changes were made.)
CG-BEH-15 - Activity Therapy for Autism Spectrum Disorders and Rett Syndrome
CG-DRUG-90 - Intravitreal Treatment for Retinal Vascular Conditions
CG-DRUG-91 - Intravitreal Corticosteroid Implants
CG-DRUG-93 - Sarilumab (Kevzara®)
CG-LAB-13 - Skin Nerve Fiber Density Testing
CG-MED-69 - Inhaled Nitric Oxide
CG-MED-70 - Wireless Capsule Endoscopy for Gastrointestinal Imaging and the Patency Capsule
CG-SURG 73 - Self-Expanding Absorptive Sinus Ostial Dilation
CG-SURG-74 - Total Ankle Replacement
CG-SURG-75 - Transanal Endoscopic Microsurgical (TEM) Excision of Rectal Lesions
CG-THER-RAD.07 - Intravascular Brachytherapy (Coronary and Non-Coronary
Revised clinical guidelines effective September 1, 2018
(The following guidelines might result in services that were previously covered now being considered not medically necessary.)
CG-DME-06 - Pneumatic Compression Devices for Lymphedema
CG-REHAB-04 - Physical Therapy
CG-REHAB-05 - Occupational Therapy
Adopted clinical guideline effective September 1, 2018
(The following guideline was adopted and might result in services that were previously covered now being considered not medically necessary.)
CG-DRUG-44 - Pegloticase (Krystexxa®)
Archived clinical guidelines effective October 31, 2018
(These guidelines are now MCG Behavioral Health Clinical Guidelines.)
CG-BEH-03 - Psychiatric Disorder Treatment
CG-BEH-04 - Substance-Related and Addictive Disorder Treatment
CG-BEH-05 - Eating and Feeding Disorder Treatment
CG-BEH-07 - Psychological Testing
CG-MED-23 - Home Health
PUBLICATIONS: June 2018 Connecticut newsletter
To view this article online:
Or scan this QR code with your phone